Heart Failure News and Research

RSS
Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
FDA approves continuous-flow heart-assist device pioneered at Texas Heart Institute at SLEH

FDA approves continuous-flow heart-assist device pioneered at Texas Heart Institute at SLEH

China Pharma Holdings announces completion of clinical trials for Candesartan

China Pharma Holdings announces completion of clinical trials for Candesartan

Vivian and Seymour Milstein Family Heart Center to open to patients in February

Vivian and Seymour Milstein Family Heart Center to open to patients in February

FDA approves Thoratec's HeartMate II LVAS for DT

FDA approves Thoratec's HeartMate II LVAS for DT

Study: Heart's ability to pump effectively is diminished among people with common lung disease

Study: Heart's ability to pump effectively is diminished among people with common lung disease

FDA approves HeartMate II for patients with severe heart failure

FDA approves HeartMate II for patients with severe heart failure

Gambro acquires CHF Solutions

Gambro acquires CHF Solutions

Erectile dysfunction can be strongly related to the development of CVD

Erectile dysfunction can be strongly related to the development of CVD

WHO, CDC issue H1N1 updates

WHO, CDC issue H1N1 updates

Japanese MHLW approves St. Jude Medical's Genesis spinal cord stimulation system

Japanese MHLW approves St. Jude Medical's Genesis spinal cord stimulation system

Health Policy Research Roundup: New Orleans clinic experiences, health reform and lagging biomedical research funds

Health Policy Research Roundup: New Orleans clinic experiences, health reform and lagging biomedical research funds

Regulus Therapeutics presents new data on oncology, immune disease and HCV therapeutic programs

Regulus Therapeutics presents new data on oncology, immune disease and HCV therapeutic programs

Findings could pave way for new therapeutic approaches for Friedreich's ataxia

Findings could pave way for new therapeutic approaches for Friedreich's ataxia

Stanford University School of Medicine adopts new, industry-funded model for continuing physicians’ education

Stanford University School of Medicine adopts new, industry-funded model for continuing physicians’ education

American Heart Association encourages more Americans to get vaccinated against H1N1

American Heart Association encourages more Americans to get vaccinated against H1N1

Cardene I.V. more effective than intravenous labetalol for BP management in acute stroke patients

Cardene I.V. more effective than intravenous labetalol for BP management in acute stroke patients

American Heart Association supports salt reduction initiative

American Heart Association supports salt reduction initiative

ARCA biopharma to receive US patent for methods of heart failure treatment with genetic testing based bucindolol

ARCA biopharma to receive US patent for methods of heart failure treatment with genetic testing based bucindolol

PDGFR's role in new blood vessel formation may explain cardiovascular side effects

PDGFR's role in new blood vessel formation may explain cardiovascular side effects

Cardiac Science and Gust Bardy launch innovation center to develop cost-effective medical products and services

Cardiac Science and Gust Bardy launch innovation center to develop cost-effective medical products and services

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.